Positron emission tomography (PET)-computed tomography (CT) is a useful device in identifying musculoskeletal lesions that require biopsy. It can be used to localize the primary lesion, identify a site to biopsy, and evaluate metastatic lesions that require follow-up biopsies. Not all malignant tumors have hypermetabolic activity, and there are many benign lesions and physiologic processes that do have increased F-18 fluorodeoxyglucose uptake. Knowledge of these issues is important when reviewing PET-CT and directing subsequent musculoskeletal biopsies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rcl.2008.02.004 | DOI Listing |
Publication Analysis
Top Keywords
positron emission
8
lesions require
8
emission tomography-ct
4
tomography-ct imaging
4
imaging guiding
4
guiding musculoskeletal
4
musculoskeletal biopsy
4
biopsy positron
4
emission tomography
4
tomography pet-computed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!